Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL. - Ermann DA; Stephens DM; Wang X; Varghese I; De Souza H; Sheetz C; Fu Q; Maglinte GA; Williams R; Seymour EK; van Beuge D; Shadman M; et al. (Oncology and therapy, 2026)